The effect of 1,25(OH)2 vitamin D3 supplementation in premature infants.
D002118:Calcium / Q000378:metabolism; D004100:Dihydroxycholecalciferols / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D006887:Hydroxycholecalciferols / Q000097:blood / Q000627:therapeutic use*; D006996:Hypocalcemia / Q000517:prevention & control*; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000517:prevention & control*; D007408:Intestinal Absorption / Q000187:drug effects; D008274:Magnesium / Q000097:blood; D010281:Parathyroid Hormone / Q000097:blood; D010758:Phosphorus / Q000097:blood; D011446:Prospective Studies
D004100:Dihydroxycholecalciferols; D006887:Hydroxycholecalciferols; D010281:Parathyroid Hormone; D010758:Phosphorus; D008274:Magnesium; D002118:Calcium